ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Vitamin D supplementation extends life in mouse model of Huntington's disease

What’s Fenugreek Good For?

Omega-3 fatty acid stops known trigger of lupus

Print Page
Email Article

Recruitment Has Begun for the Osteoarthritis Initiative (March 2004)

  [ 88 votes ]   [ Discuss This Article ] • March 17, 2004

NIH News National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) FOR IMMEDIATE RELEASE Wednesday, March 17, 2004 CONTACT: Liz Freedman 301-496-8190


Recruitment has begun for the Osteoarthritis Initiative (OAI), a public-private partnership between the National Institutes of Health and industry that funds a multisite contract to create a resource to hasten discovery of biological markers for osteoarthritis (OA). Men and women age 45 and older at risk for developing OA and those with early disease are eligible to participate. After an initial screening, four centers around the United States plan to each enroll and follow 1,250 adults for five years (total enrollment of 5,000). Biological specimens (blood, urine, DNA), images (X-rays and magnetic resonance scans) and clinical data will be collected annually.

Biological markers -- physical signs or biological substances that indicate changes in bone or cartilage -- are critical in diagnosing and monitoring OA and developing new treatments. Ultimately, results from the OAI may enable doctors to use biological markers to help identify people at risk for OA and people with OA at risk for disease progression. The markers could also help doctors assess the effectiveness of treatments.

The four clinical centers, selected in the summer of 2002, include the University of Maryland School of Medicine/Johns Hopkins University, the Ohio State University Medical Center, the University of Pittsburgh and the Memorial Hospital of Rhode Island/Brown University. A data coordinating center at the University of California, San Francisco oversees the study conduct and will manage the resulting data. The Ohio State University and University of Pittsburgh centers enrolled their first participants the week of February 23, and centers in Maryland and Rhode Island will begin enrollment in late March and early April.
The clinical centers may be contacted at:
Ms. Raushanah Kareem University of Maryland 10 South Pine Street, Room 8-34, MSTF Baltimore, MD 21201 (410) 706-5791 or (866) 565-KNEE (toll free)
Osteoarthritis Initiative The Ohio State University 198 McCampbell Hall 1581 Dodd Drive Columbus, OH 43210 (614) 688-3563 or (800) 251-1175 (toll free)
Study Office/GSPH University of Pittsburgh 4200 Fifth Avenue Pittsburgh, PA 15213-9910 (800) 872-3653 (toll free)
Osteoarthritis Initiative Memorial Hospital of Rhode Island/Brown University ATTN: Doris Moore 111 Brewster Street, CPCP Building, 2nd Floor Pawtucket, RI 02860 (800) 877-3347 (toll free)

Osteoarthritis, a degenerative condition whose hallmarks are joint pain and limited movement resulting from progressive loss of cartilage, is the most common type of arthritis, especially among older people. It can occur in any joint, but most often affects the hands, knees, hips or spine. There are currently no treatments, other than surgical joint replacement, that significantly change the course of this joint disease, and clinical trials for new therapies are long, difficult and expensive.

The OAI is a federal contract funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute on Aging (NIA), Office of Research on Women's Health, National Institute of Dental and Craniofacial Research, National Center on Minority Health and Health Disparities and National Center for Complementary and Alternative Medicine, all part of the Department of Health and Human Services' National Institutes of Health. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation; and Pfizer Inc.

Private sector funding for the OAI is being managed by the Foundation for the National Institutes of Health. For information on the OAI, visit "The OAI: A Knee Health Study" at For general questions, visit The NIAMS Office of Communications and Public Liaison (301-496- 8190) or the NIA Communications Office (301-496-1752) can also be contacted for information.

The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the Department of Health and Human Services' National Institutes of Health, is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases. For more information about NIAMS, call the information clearinghouse at (301) 495-4484 or (877) 22- NIAMS (free call) or visit the NIAMS Web site at

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Energy NADH™ 12.5mg Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season
Eating Fat is Good... Maybe... Could Be... Sometimes Eating Fat is Good... Maybe... Could Be... Sometimes
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Improve Cardiovascular and Metabolic Health with Omega-7 Improve Cardiovascular and Metabolic Health with Omega-7

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map